Cytolysin: Difference between revisions
CSV import |
CSV import |
||
| Line 35: | Line 35: | ||
{{stub}} | {{stub}} | ||
== Cytolysin == | |||
<gallery> | |||
File:Pore_structure_representation_3.png|Pore structure representation 3 | |||
File:Pore_structure_representation_2.png|Pore structure representation 2 | |||
File:Pore_forming_cytolysin_1.png|Pore forming cytolysin 1 | |||
File:Pore_forming_cytolysin_2.png|Pore forming cytolysin 2 | |||
File:Pore_forming_cytolysin_3.png|Pore forming cytolysin 3 | |||
</gallery> | |||
Latest revision as of 21:31, 23 February 2025
Cytolysin is a type of toxin produced by certain bacteria that is capable of lysing cells by forming pores in the cell membrane. This process is known as cytolysis, which can lead to cell death. Cytolysins are a major virulence factor for many pathogenic bacteria.
Types of Cytolysin[edit]
There are several types of cytolysins, each with unique properties and mechanisms of action. Some of the most well-known include:
- Streptolysin: This is a cytolysin produced by Streptococcus bacteria. There are two types: Streptolysin O and Streptolysin S. Streptolysin O is oxygen-labile and antigenic, while Streptolysin S is oxygen-stable and non-antigenic.
- Listeriolysin O: This is a cytolysin produced by Listeria monocytogenes, a bacterium that causes listeriosis. Listeriolysin O is crucial for the bacterium's ability to escape from the phagosome into the cytosol of the host cell.
- Pneumolysin: This is a cytolysin produced by Streptococcus pneumoniae, a bacterium that causes pneumonia. Pneumolysin is a cholesterol-dependent cytolysin, meaning it binds to cholesterol in the host cell membrane to form pores.
Mechanism of Action[edit]
Cytolysins exert their effects by forming pores in the cell membrane of the host organism. This disrupts the normal function of the membrane, leading to a loss of essential molecules and ions, disruption of the membrane potential, and ultimately, cell death.
Clinical Significance[edit]
Cytolysins are a major virulence factor for many pathogenic bacteria, contributing to their ability to cause disease. They are also a target for the development of new antibacterial therapies.
